SciELO - Scientific Electronic Library Online

 
vol.142 número2Calidad de vida relacionada con la salud en una muestra de médicos internos residentes que realizan guardias en un Servicio de Urgencias: una perspectiva de géneroNeurobiología del trastorno de personalidad límite índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

ISA O, Nicolás; RUSSO N, Moisés  y  LOPEZ V, Hernán. Adjuvant chemoradiotherapy in advanced gastric cancer: Experience in 168 patients. Rev. méd. Chile [online]. 2014, vol.142, n.2, pp.199-203. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872014000200008.

Background: Gastric cancer is one of the most lethal tumors in the Chilean population. Aim: To report the results of adjuvant chemoradiotherapy in advanced gastric cancer. Material and Methods: Review of medical records of patients with locoregionally advanced gastric cancer, subjected to a curative resection and treated with adjuvant chemoradiotherapy. The treatment was based on the INT 0116/SWOG protocol, which includes 5-fuorouracil as a single agent. Patients were followed for a median of 58 months. Results: the records of 168 patients (99 men) treated between 2004 and 2011, were reviewed. Median survival was 41 months. Median lapses between surgery and onset of chemo and radiotherapy were 12 and 17 weeks, respectively. Overall three and five years survival was 53 and 41%, respectively. On multivariate analysis the factors associated with a lower survival were an antral location of the tumor, presence of signet ring cells and more than 15 involved lymph nodes. Conclusions: Three and five years survival of gastric cancer patients subjected to adjuvant chemoradiotherapy was 53 and 41% respectively. These results are similar to those reported elsewhere.

Palabras clave : Drug therapy; Radiotherapy; Stomach neoplasms.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons